1. Home
  2. Labeler Index
  3. Macrogenics, Inc
  4. 74527-022
  5. NDC Package Code: 74527-022-03 Margenza

NDC Package 74527-022-03 Margenza

Margetuximab-cmkb Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
74527-022-03
Package Description:
4 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)
Product Code:
74527-022
Proprietary Name:
Margenza
Non-Proprietary Name:
Margetuximab-cmkb
Substance Name:
Margetuximab
Usage Information:
MARGENZA is indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease [see Dosage and Administration (2.1) and Clinical Studies (14.1)].
11-Digit NDC Billing Format:
74527002203
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2474028 - margetuximab-cmkb 250 MG in 10 ML Injection
  • RxCUI: 2474028 - 10 ML margetuximab-cmkb 25 MG/ML Injection
  • RxCUI: 2474028 - margetuximab-cmkb 250 MG per 10 ML Injection
  • RxCUI: 2474033 - Margenza 250 MG in 10 ML Injection
  • RxCUI: 2474033 - 10 ML margetuximab-cmkb 25 MG/ML Injection [Margenza]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Macrogenics, Inc
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • MARGETUXIMAB 25 mg/mL
    • Pharmacologic Class(es):
  • HER2/Neu/cerbB2 Antagonists - [MoA] (Mechanism of Action)
  • HER2/neu Receptor Antagonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA761150
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    01-15-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 74527-022-03 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    74527002203J9353Inj. margetuximab-cmkb, 5 mg5 MG10450200

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    74527-022-021 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 74527-022-03?

    The NDC Packaged Code 74527-022-03 is assigned to a package of 4 vial, single-dose in 1 carton / 10 ml in 1 vial, single-dose (74527-022-01) of Margenza, a human prescription drug labeled by Macrogenics, Inc. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 74527-022 included in the NDC Directory?

    Yes, Margenza with product code 74527-022 is active and included in the NDC Directory. The product was first marketed by Macrogenics, Inc on January 15, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 74527-022-03?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 74527-022-03?

    The 11-digit format is 74527002203. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-274527-022-035-4-274527-0022-03